SLXP Insider Trading Activity and SEC Form 4 Filings
SLXP insider trading summary
No open-market insider purchases or sales of Salix Pharmaceuticals Ltd (SLXP) have been reported on SEC Form 4 in the past 12 months.
Latest SLXP insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 9, 2015 | William P Forbes | President, Medical R&D and CDO | Sell | $6.8M (42,880 @ $157.84) |
| Mar 6, 2015 | William P Forbes | EVP Research&Devel & CDO | Sell | $3.2M (20,000 @ $157.96) |
| Mar 6, 2015 | Rick D Scruggs | Executive Vice President | Sell | $630K (4,000 @ $157.55) |
| Mar 6, 2015 | Timothy J Creech | See Remarks | Sell | $725K (4,600 @ $157.67) |
| Nov 12, 2014 | William P Forbes | EVP Research&Devel & CDO | Sell | $1.1M (11,079 @ $95.05) |
| Jun 26, 2014 | Carolyn J Logan | President & CEO | Sell | $2.4M (19,200 @ $123.87) |
| Jun 26, 2014 | Carolyn J Logan | President & CEO | Sell | $122K (1,000 @ $122.38) |
| Jun 26, 2014 | Carolyn J Logan | President & CEO | Sell | $4.0M (32,857 @ $123.13) |
| May 16, 2014 | Rick D Scruggs | Executive Vice President | Sell | $95K (900 @ $105.67) |
| Apr 22, 2014 | Alonzo Thomas D | Director | Sell | $203K (1,800 @ $112.54) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.